Ferkauf Graduate School of Psychology, Yeshiva University, Bronx, NY, USA.
Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY, USA.
Nicotine Tob Res. 2022 Mar 26;24(5):643-653. doi: 10.1093/ntr/ntab201.
This paper reports on topics discussed at a Society for Research on Nicotine and Tobacco pre-conference workshop at the 2019 annual Society for Research on Nicotine and Tobacco meeting. The goal of the pre-conference workshop was to help develop a shared understanding of the importance of several tobacco-related priority groups in tobacco use disorder (TUD) treatment research and to highlight challenges in measurement related to these groups. The workshop focused on persons with minoritized sex, gender identity, and sexual orientation identities; persons with minoritized racial and ethnic backgrounds; persons with lower socioeconomic status (SES); and persons with mental health concerns. In addition to experiencing commercial tobacco-related health disparities, these groups are also underrepresented in tobacco research, including TUD treatment studies. Importantly, there is wide variation in how and whether researchers are identifying variation within these priority groups. Best practices for measuring and reporting sex, gender identity, sexual orientation, race, ethnicity, SES, and mental health concerns in TUD treatment research are needed. This paper provides information about measurement challenges when including these groups in TUD treatment research and specific recommendations about how to measure these groups and assess potential disparities in outcomes. The goal of this paper is to encourage TUD treatment researchers to use measurement best practices in these priority groups in an effort to conduct meaningful and equity-promoting research. Increasing the inclusion and visibility of these groups in TUD treatment research will help to move the field forward in decreasing tobacco-related health disparities. Implications: Tobacco-related disparities exist for a number of priority groups including, among others, women, individuals with minoritized sexual and gender identities, individuals with minoritized racial and ethnic backgrounds, individuals with lower SES, and individuals with mental health concerns. Research on TUD treatments for many of these subgroups is lacking. Accurate assessment and consideration of these subgroups will provide needed information about efficacious and effective TUD treatments, about potential mediators and moderators, and for accurately describing study samples, all critical elements for reducing tobacco-related disparities, and improving diversity, equity, and inclusion in TUD treatment research.
本文报告了在 2019 年美国国家药物滥用研究所烟草研究学会年会上举行的一次社会研究尼古丁与烟草会前研讨会讨论的主题。本次会前研讨会的目标是帮助人们更好地理解在烟草使用障碍（TUD）治疗研究中几个与烟草相关的优先群体的重要性，并强调与这些群体相关的测量挑战。该研讨会重点关注具有少数性别的人、性别认同和性取向身份；具有少数族裔和族裔背景的人；社会经济地位较低的人；以及有心理健康问题的人。除了经历与商业烟草相关的健康差距外，这些群体在烟草研究中，包括 TUD 治疗研究中，也代表性不足。重要的是，研究人员在识别这些优先群体内部的差异方面的方式和是否存在差异存在很大差异。需要制定 TUD 治疗研究中测量和报告性、性别认同、性取向、种族、族裔、社会经济地位和心理健康问题的最佳实践。本文提供了在 TUD 治疗研究中纳入这些群体时遇到的测量挑战的信息，并就如何测量这些群体以及评估结果中的潜在差异提出了具体建议。本文的目的是鼓励 TUD 治疗研究人员在这些优先群体中使用测量最佳实践，以进行有意义和促进公平的研究。增加这些群体在 TUD 治疗研究中的纳入和可见度将有助于推动该领域减少与烟草相关的健康差距。意义：一些优先群体存在与烟草相关的差异，包括女性、具有少数性别的人和性别认同、具有少数族裔和族裔背景的人、社会经济地位较低的人以及有心理健康问题的人。针对这些亚组的 TUD 治疗研究很少。对这些亚组的准确评估和考虑将提供关于有效和有效的 TUD 治疗、潜在的中介和调节因素以及准确描述研究样本的信息，这些都是减少与烟草相关的差异、改善 TUD 治疗研究中的多样性、公平性和包容性的关键要素。
